Silver nanoparticles synthesized from Pseudomonas aeruginosa pyoverdine: Antibiofilm and antivirulence agents

The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the healthcare sector. In the present study, nanomaterial-based controlling the biofilm and virulence properties has been considered an alternative...

Full description

Saved in:
Bibliographic Details
Published inBiofilm Vol. 7; p. 100192
Main Authors Tabassum, Nazia, Khan, Fazlurrahman, Jeong, Geum-Jae, Jo, Du-Min, Kim, Young-Mog
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.06.2024
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the healthcare sector. In the present study, nanomaterial-based controlling the biofilm and virulence properties has been considered an alternative approach. Pyoverdine (PVD) isolated from the Pseudomonas aeruginosa was utilized as a biological corona to synthesize silver nanoparticles (AgNPs), which will be helpful in a targeted action to microbial pathogens due to the recognition of the corona of the nanoparticles by the pathogenic membrane. Synthesized PVD-AgNPs were spherical to irregular, with an average size value of 251.87 ± 21.8 nm and zeta potential with a value of −36.51 ± 0.69 mV. The MIC value of PVD-AgNPs towards P. aeruginosa, Listeria monocytogenes, Staphylococcus aureus, Streptococcus mutans, Escherichia coli, and Candida albicans in the standard and host-mimicking media were observed in decreasing order in a multi-fold, such as standard growth media > sputum > synthetic human urine > saliva. Both the initial stage and the well-established biofilms of these microbial pathogens have been effectively inhibited and eradicated by PVD-AgNPs. PVD-AgNPs increase the susceptibility of tetracycline, PVD, and amphotericin B towards established mature mono- and mixed-species biofilms of S. aureus and C. albicans. Additionally, PVD-AgNPs attenuate several virulence properties, such as inhibition of protease activity, motility, and PVD and pyocyanin production in P. aeruginosa. The inhibition of gene expression of biofilm and virulence-associated genes in P. aeruginosa validates its phenotypic effects. •Pyoverdine from Pseudomonas aeruginosa was used as a biological corona to synthesize AgNPs.•PVD-AgNPs effectively inhibited and eradicated initial stage and mature biofilms.•PVD-AgNPs increased the susceptibility of tetracycline and amphotericin B towards mature biofilm.•PVD-AgNPs attenuated several virulence properties in P. aeruginosa.•The suppression of genes associated with biofilm and virulence validates its phenotypic effects.
AbstractList The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the healthcare sector. In the present study, nanomaterial-based controlling the biofilm and virulence properties has been considered an alternative approach. Pyoverdine (PVD) isolated from the Pseudomonas aeruginosa was utilized as a biological corona to synthesize silver nanoparticles (AgNPs), which will be helpful in a targeted action to microbial pathogens due to the recognition of the corona of the nanoparticles by the pathogenic membrane. Synthesized PVD-AgNPs were spherical to irregular, with an average size value of 251.87 ± 21.8 nm and zeta potential with a value of −36.51 ± 0.69 mV. The MIC value of PVD-AgNPs towards P. aeruginosa, Listeria monocytogenes, Staphylococcus aureus, Streptococcus mutans, Escherichia coli, and Candida albicans in the standard and host-mimicking media were observed in decreasing order in a multi-fold, such as standard growth media > sputum > synthetic human urine > saliva. Both the initial stage and the well-established biofilms of these microbial pathogens have been effectively inhibited and eradicated by PVD-AgNPs. PVD-AgNPs increase the susceptibility of tetracycline, PVD, and amphotericin B towards established mature mono- and mixed-species biofilms of S. aureus and C. albicans. Additionally, PVD-AgNPs attenuate several virulence properties, such as inhibition of protease activity, motility, and PVD and pyocyanin production in P. aeruginosa. The inhibition of gene expression of biofilm and virulence-associated genes in P. aeruginosa validates its phenotypic effects.
The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the healthcare sector. In the present study, nanomaterial-based controlling the biofilm and virulence properties has been considered an alternative approach. Pyoverdine (PVD) isolated from the was utilized as a biological corona to synthesize silver nanoparticles (AgNPs), which will be helpful in a targeted action to microbial pathogens due to the recognition of the corona of the nanoparticles by the pathogenic membrane. Synthesized PVD-AgNPs were spherical to irregular, with an average size value of 251.87 ± 21.8 nm and zeta potential with a value of -36.51 ± 0.69 mV. The MIC value of PVD-AgNPs towards , , , , , and in the standard and host-mimicking media were observed in decreasing order in a multi-fold, such as standard growth media > sputum > synthetic human urine > saliva. Both the initial stage and the well-established biofilms of these microbial pathogens have been effectively inhibited and eradicated by PVD-AgNPs. PVD-AgNPs increase the susceptibility of tetracycline, PVD, and amphotericin B towards established mature mono- and mixed-species biofilms of and . Additionally, PVD-AgNPs attenuate several virulence properties, such as inhibition of protease activity, motility, and PVD and pyocyanin production in . The inhibition of gene expression of biofilm and virulence-associated genes in validates its phenotypic effects.
The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the healthcare sector. In the present study, nanomaterial-based controlling the biofilm and virulence properties has been considered an alternative approach. Pyoverdine (PVD) isolated from the Pseudomonas aeruginosa was utilized as a biological corona to synthesize silver nanoparticles (AgNPs), which will be helpful in a targeted action to microbial pathogens due to the recognition of the corona of the nanoparticles by the pathogenic membrane. Synthesized PVD-AgNPs were spherical to irregular, with an average size value of 251.87 ± 21.8 nm and zeta potential with a value of -36.51 ± 0.69 mV. The MIC value of PVD-AgNPs towards P. aeruginosa, Listeria monocytogenes, Staphylococcus aureus, Streptococcus mutans, Escherichia coli, and Candida albicans in the standard and host-mimicking media were observed in decreasing order in a multi-fold, such as standard growth media > sputum > synthetic human urine > saliva. Both the initial stage and the well-established biofilms of these microbial pathogens have been effectively inhibited and eradicated by PVD-AgNPs. PVD-AgNPs increase the susceptibility of tetracycline, PVD, and amphotericin B towards established mature mono- and mixed-species biofilms of S. aureus and C. albicans. Additionally, PVD-AgNPs attenuate several virulence properties, such as inhibition of protease activity, motility, and PVD and pyocyanin production in P. aeruginosa. The inhibition of gene expression of biofilm and virulence-associated genes in P. aeruginosa validates its phenotypic effects.
The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the healthcare sector. In the present study, nanomaterial-based controlling the biofilm and virulence properties has been considered an alternative approach. Pyoverdine (PVD) isolated from the Pseudomonas aeruginosa was utilized as a biological corona to synthesize silver nanoparticles (AgNPs), which will be helpful in a targeted action to microbial pathogens due to the recognition of the corona of the nanoparticles by the pathogenic membrane. Synthesized PVD-AgNPs were spherical to irregular, with an average size value of 251.87 ± 21.8 nm and zeta potential with a value of −36.51 ± 0.69 mV. The MIC value of PVD-AgNPs towards P. aeruginosa , Listeria monocytogenes , Staphylococcus aureus , Streptococcus mutans , Escherichia coli , and Candida albicans in the standard and host-mimicking media were observed in decreasing order in a multi-fold, such as standard growth media > sputum > synthetic human urine > saliva. Both the initial stage and the well-established biofilms of these microbial pathogens have been effectively inhibited and eradicated by PVD-AgNPs. PVD-AgNPs increase the susceptibility of tetracycline, PVD, and amphotericin B towards established mature mono- and mixed-species biofilms of S. aureus and C. albicans . Additionally, PVD-AgNPs attenuate several virulence properties, such as inhibition of protease activity, motility, and PVD and pyocyanin production in P. aeruginosa . The inhibition of gene expression of biofilm and virulence-associated genes in P. aeruginosa validates its phenotypic effects. • Pyoverdine from Pseudomonas aeruginosa was used as a biological corona to synthesize AgNPs. • PVD-AgNPs effectively inhibited and eradicated initial stage and mature biofilms. • PVD-AgNPs increased the susceptibility of tetracycline and amphotericin B towards mature biofilm. • PVD-AgNPs attenuated several virulence properties in P. aeruginosa. • The suppression of genes associated with biofilm and virulence validates its phenotypic effects.
The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the healthcare sector. In the present study, nanomaterial-based controlling the biofilm and virulence properties has been considered an alternative approach. Pyoverdine (PVD) isolated from the Pseudomonas aeruginosa was utilized as a biological corona to synthesize silver nanoparticles (AgNPs), which will be helpful in a targeted action to microbial pathogens due to the recognition of the corona of the nanoparticles by the pathogenic membrane. Synthesized PVD-AgNPs were spherical to irregular, with an average size value of 251.87 ± 21.8 nm and zeta potential with a value of −36.51 ± 0.69 mV. The MIC value of PVD-AgNPs towards P. aeruginosa, Listeria monocytogenes, Staphylococcus aureus, Streptococcus mutans, Escherichia coli, and Candida albicans in the standard and host-mimicking media were observed in decreasing order in a multi-fold, such as standard growth media > sputum > synthetic human urine > saliva. Both the initial stage and the well-established biofilms of these microbial pathogens have been effectively inhibited and eradicated by PVD-AgNPs. PVD-AgNPs increase the susceptibility of tetracycline, PVD, and amphotericin B towards established mature mono- and mixed-species biofilms of S. aureus and C. albicans. Additionally, PVD-AgNPs attenuate several virulence properties, such as inhibition of protease activity, motility, and PVD and pyocyanin production in P. aeruginosa. The inhibition of gene expression of biofilm and virulence-associated genes in P. aeruginosa validates its phenotypic effects. •Pyoverdine from Pseudomonas aeruginosa was used as a biological corona to synthesize AgNPs.•PVD-AgNPs effectively inhibited and eradicated initial stage and mature biofilms.•PVD-AgNPs increased the susceptibility of tetracycline and amphotericin B towards mature biofilm.•PVD-AgNPs attenuated several virulence properties in P. aeruginosa.•The suppression of genes associated with biofilm and virulence validates its phenotypic effects.
ArticleNumber 100192
Author Tabassum, Nazia
Jeong, Geum-Jae
Kim, Young-Mog
Khan, Fazlurrahman
Jo, Du-Min
Author_xml – sequence: 1
  givenname: Nazia
  surname: Tabassum
  fullname: Tabassum, Nazia
  organization: Marine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan, 48513, Republic of Korea
– sequence: 2
  givenname: Fazlurrahman
  orcidid: 0000-0002-4902-3188
  surname: Khan
  fullname: Khan, Fazlurrahman
  email: fkhan055@pknu.ac.kr
  organization: Marine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan, 48513, Republic of Korea
– sequence: 3
  givenname: Geum-Jae
  surname: Jeong
  fullname: Jeong, Geum-Jae
  organization: Department of Food Science and Technology, Pukyong National University, Busan, 48513, Republic of Korea
– sequence: 4
  givenname: Du-Min
  surname: Jo
  fullname: Jo, Du-Min
  organization: Marine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan, 48513, Republic of Korea
– sequence: 5
  givenname: Young-Mog
  surname: Kim
  fullname: Kim, Young-Mog
  organization: Marine Integrated Biomedical Technology Center, The National Key Research Institutes in Universities, Pukyong National University, Busan, 48513, Republic of Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38544742$$D View this record in MEDLINE/PubMed
BookMark eNp9kclqHDEQhoVxiNc3MKGPucyktPSWQ4IxcWIwJJD4LNRSaayhW5pI3QPjp48mPTH2JQchUfrrq-U_I8c-eCTkisKSAq0-rJedC7YflgyYyCGgLTsip6xsYcGgLo9fvE_IZUprAGCc8prBW3LCm1KIWrBTMvx0_RZj4ZUPGxVHp3tMRdr58RGTe0JT2BiG4kfCyYQheJUKhXFaOR-SKja7kJON8_ixuPaj2zfl-qFQ3uQzuq2LU49eY6FW6Md0Qd5Y1Se8PNzn5OH2y6-bb4v771_vbq7vF7rkMC4M70C1TccrVrMONSpbMU21ooxpYYXVVVcDaEprLQRvTFNX2lQlFXXXtFXFz8ndzDVBreUmukHFnQzKyb-BEFfyMKuktm5LC8h10wkNttMGMgpoLm5ag5n1eWZtpm5Ao_McUfWvoK9_vHuUq7CVFHIrtOWZ8P5AiOH3hGmUg0sa-155DFOSHKgAKKFlWSpmqY4hpYj2uQ4FuXderuXsvNw7L2fnc9q7lz0-J_3zOQs-zQLMW986jDJptzfGuIh6zGtx_6_wBxOixi4
CitedBy_id crossref_primary_10_1016_j_resmic_2024_104211
crossref_primary_10_3390_antibiotics13040347
Cites_doi 10.3390/antibiotics11111524
10.1093/cid/ciac489
10.1002/jobm.202000678
10.1371/journal.pone.0089614
10.1128/JCM.01934-17
10.1007/s00203-021-02505-1
10.1007/s42770-021-00624-x
10.1371/journal.pone.0176883
10.1016/j.matchemphys.2020.122898
10.1080/21691401.2018.1518909
10.1016/j.ebiom.2017.05.026
10.3390/md20080527
10.1038/nrmicro2415
10.1080/14787210.2021.1908125
10.1097/CCM.0b013e3181e96b91
10.1080/1040841X.2023.2282459
10.1016/j.mimet.2019.02.010
10.1007/s11356-016-8170-3
10.1016/S0140-6736(21)02724-0
10.1186/s13756-019-0533-3
10.1016/j.febslet.2011.12.004
10.1016/j.cplett.2016.11.037
10.3390/jof7121070
10.1016/j.jep.2020.113699
10.1186/s12951-023-01909-z
10.1128/AEM.04220-14
10.3390/biomedicines10030628
10.1038/nprot.2008.73
10.1016/j.jare.2022.12.013
10.1080/1040841X.2020.1822278
10.3390/pathogens11030300
10.1093/cid/ciy776
10.1128/CMR.05041-11
10.1038/s41598-019-52975-z
10.1007/s00284-010-9722-2
10.1089/mdr.2020.0089
10.1016/j.chemosphere.2022.134497
10.1038/s41392-022-01056-1
10.1016/j.ijmm.2017.09.016
10.1021/acsomega.2c06789
10.1007/s13205-019-1841-2
10.1038/s41579-022-00682-4
10.3390/antibiotics12040726
10.3389/fcimb.2017.00041
10.1038/s41467-022-32249-5
10.1016/j.tim.2016.12.010
10.1078/1438-4221-00196
10.3390/molecules26041142
10.1038/s41579-022-00720-1
10.5001/omj.2019.37
10.1016/j.chemosphere.2020.128580
10.1038/s41579-021-00649-x
10.1155/2017/9584703
10.3934/microbiol.2018.2.274
10.1016/j.micres.2014.05.005
10.1007/s00253-019-10190-w
10.1039/D2NR03632K
10.3390/md21020123
10.1128/AAC.02533-15
10.1016/j.ijantimicag.2023.106941
10.3390/md17040208
10.3390/md19110601
10.3390/nano12010130
10.3389/fmicb.2021.741493
10.1038/s41396-022-01218-7
10.1016/j.micpath.2023.106416
10.1080/1040841X.2021.1921696
10.1021/acsami.2c05979
10.1038/nrmicro821
10.1111/j.1462-2920.2010.02308.x
10.1039/C5RA20856D
10.1007/s00253-022-12347-6
10.1590/S1517-83822012000300013
10.1039/C4NR04970E
10.1016/j.micpath.2016.06.016
10.3389/fmicb.2016.01366
10.1016/j.colsurfb.2021.112307
10.1038/s41522-022-00327-7
10.3389/fcimb.2021.656984
10.1046/j.1472-765X.1997.00378.x
10.1016/j.micpath.2022.105678
10.1099/jmm.0.45969-0
10.1038/s41579-018-0141-x
ContentType Journal Article
Copyright 2024 The Author(s)
2024 The Author(s).
2024 The Author(s) 2024
Copyright_xml – notice: 2024 The Author(s)
– notice: 2024 The Author(s).
– notice: 2024 The Author(s) 2024
DBID 6I.
AAFTH
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1016/j.bioflm.2024.100192
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2590-2075
EndPage 100192
ExternalDocumentID oai_doaj_org_article_1f795f0e3c8b4c0fbcd0d6501362d9de
10_1016_j_bioflm_2024_100192
38544742
S2590207524000170
Genre Journal Article
GroupedDBID 0SF
6I.
AAEDW
AAFTH
AALRI
AAXUO
AEXQZ
AITUG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
EBS
EJD
FDB
GROUPED_DOAJ
M41
NCXOZ
OK1
ROL
RPM
ADVLN
AFJKZ
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c530t-d3b0a98b36272beceaf62c1ca122c4f4fc6b700c117c4438d876cd65147b89663
IEDL.DBID RPM
ISSN 2590-2075
IngestDate Tue Oct 22 15:15:14 EDT 2024
Tue Sep 17 21:29:24 EDT 2024
Sat Oct 26 05:54:05 EDT 2024
Thu Sep 26 18:03:39 EDT 2024
Sat Nov 02 12:15:32 EDT 2024
Wed Jun 26 17:51:35 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Antivirulence
Antibiofilm
Pyoverdine
Silver nanoparticles
Host-mimicking media
Language English
License This is an open access article under the CC BY-NC-ND license.
2024 The Author(s).
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c530t-d3b0a98b36272beceaf62c1ca122c4f4fc6b700c117c4438d876cd65147b89663
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-4902-3188
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10966193/
PMID 38544742
PQID 3014005092
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_1f795f0e3c8b4c0fbcd0d6501362d9de
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10966193
proquest_miscellaneous_3014005092
crossref_primary_10_1016_j_bioflm_2024_100192
pubmed_primary_38544742
elsevier_sciencedirect_doi_10_1016_j_bioflm_2024_100192
PublicationCentury 2000
PublicationDate 2024-06-01
PublicationDateYYYYMMDD 2024-06-01
PublicationDate_xml – month: 06
  year: 2024
  text: 2024-06-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Biofilm
PublicationTitleAlternate Biofilm
PublicationYear 2024
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Benedict (bib4) 2019; 68
Khan (bib62) 2020; 46
Brooks, Keevil (bib44) 1997; 24
Kim (bib72) 2014; 6
Larsson, Flach (bib1) 2022; 20
Tuon (bib88) 2022; 11
Stewart (bib76) 2002; 292
Baldan (bib13) 2014; 9
Singh, Mijakovic (bib32) 2022; 10
Kumar (bib60) 2017; 307
Highmore (bib61) 2022; 8
Tyers, Wright (bib81) 2019; 17
Asokan (bib7) 2019; 34
Kang (bib48) 2022; 11
Jeong (bib65) 2023
Liu (bib23) 2016; 7
Mohamed (bib86) 2020; 26
Jeong (bib78) 2023
Murray (bib6) 2022; 399
Who (bib9) October 2022
Who (bib8) March 2017
Tabassum (bib29) 2023; 21
Vanitha (bib70) 2017; 669
Sharma (bib73) 2021; 7
Garcia Maset (bib12) 2022; 14
Dragoš, Kovács (bib59) 2017; 25
Naik, Dubey (bib68) 2011; 62
Sharma, Misba, Khan (bib22) 2019; 8
Tabassum (bib46) 2023
Qin (bib87) 2022; 7
Jeong (bib41) 2023
Khorsandi (bib28) 2021; 19
Kumar, Paliya, Singh (bib89) 2022; 170
Khan (bib49) 2022; 211
Rather, Gupta, Mandal (bib66) 2021; 269
Jeong (bib64) 2023
Tamma, Cosgrove, Maragakis (bib80) 2012; 25
Khan (bib45) 2021; 19
Kumar (bib82) 2010; 38
Dutt (bib25) 2023; 21
Hall-Stoodley, Costerton, Stoodley (bib20) 2004; 2
Khan (bib84) 2021; 47
Du (bib74) 2017; 7
Flemming, Wingender (bib58) 2010; 8
Kyaw, Lim (bib83) 2012; 43
Di Martino (bib19) 2018; 4
Luo (bib56) 2017; 12
Hannauer (bib67) 2012; 586
Indira (bib38) 2019; 9
Oura (bib55) 2015; 81
Saravanan (bib37) 2021; 264
J (bib43) 2017; 68
Jebril, Jenana, Dridi (bib71) 2020; 248
Khan (bib30) 2023; 12
Khan (bib47) 2019; 17
Gold (bib5) 2022; 76
Furiga (bib51) 2015; 60
Sriramulu (bib42) 2005; 54
Rani (bib40) 2021; 26
Rather, Gupta, Mandal (bib18) 2021; 52
Saeki (bib79) 2021; 11
Lee (bib53) 2014; 169
Ahamad (bib77) 2022; 12
Fisher (bib3) 2022; 20
Rather (bib21) 2021; 61
Khan (bib50) 2020; 104
Dane (bib33) 2016; 6
Jeong (bib63) 2023
Ciofu (bib17) 2022; 20
Singh (bib31) 2018; 46
Abdelghani (bib39) 2021; 203
Schmittgen, Livak (bib57) 2008; 3
Rather (bib26) 2022; 300
Ali (bib36) 2019; 159
Khan (bib85) 2023; 53
Kumari, Barsainya, Singh (bib69) 2017; 24
Orazi, Jean-Pierre, O'Toole (bib14) 2020
Jeong (bib34) 2022; 20
Fu (bib52) 2017; 2017
Briaud (bib15) 2019; 9
Nadeem (bib35) 2022; 12
Ahmed (bib75) 2016; 98
O'Brien, Figueroa, Welch (bib16) 2022; 16
Kang (bib27) 2023
Lee, Cho, Lee (bib54) 2011; 13
Ersoy (bib11) 2017; 20
Khan (bib24) 2022; 14
Gow (bib2) 2022; 13
Humphries (bib10) 2018; 56
Vanitha (10.1016/j.bioflm.2024.100192_bib70) 2017; 669
Rather (10.1016/j.bioflm.2024.100192_bib18) 2021; 52
Hall-Stoodley (10.1016/j.bioflm.2024.100192_bib20) 2004; 2
Dragoš (10.1016/j.bioflm.2024.100192_bib59) 2017; 25
Ahmed (10.1016/j.bioflm.2024.100192_bib75) 2016; 98
Khan (10.1016/j.bioflm.2024.100192_bib84) 2021; 47
Ciofu (10.1016/j.bioflm.2024.100192_bib17) 2022; 20
Abdelghani (10.1016/j.bioflm.2024.100192_bib39) 2021; 203
Schmittgen (10.1016/j.bioflm.2024.100192_bib57) 2008; 3
Lee (10.1016/j.bioflm.2024.100192_bib53) 2014; 169
Humphries (10.1016/j.bioflm.2024.100192_bib10) 2018; 56
Rather (10.1016/j.bioflm.2024.100192_bib26) 2022; 300
Ali (10.1016/j.bioflm.2024.100192_bib36) 2019; 159
Jeong (10.1016/j.bioflm.2024.100192_bib65) 2023
Gold (10.1016/j.bioflm.2024.100192_bib5) 2022; 76
Dutt (10.1016/j.bioflm.2024.100192_bib25) 2023; 21
Kim (10.1016/j.bioflm.2024.100192_bib72) 2014; 6
Nadeem (10.1016/j.bioflm.2024.100192_bib35) 2022; 12
Jebril (10.1016/j.bioflm.2024.100192_bib71) 2020; 248
Sharma (10.1016/j.bioflm.2024.100192_bib73) 2021; 7
Di Martino (10.1016/j.bioflm.2024.100192_bib19) 2018; 4
Jeong (10.1016/j.bioflm.2024.100192_bib78) 2023
Khan (10.1016/j.bioflm.2024.100192_bib85) 2023; 53
J (10.1016/j.bioflm.2024.100192_bib43) 2017; 68
Khan (10.1016/j.bioflm.2024.100192_bib49) 2022; 211
Ahamad (10.1016/j.bioflm.2024.100192_bib77) 2022; 12
Sharma (10.1016/j.bioflm.2024.100192_bib22) 2019; 8
Kyaw (10.1016/j.bioflm.2024.100192_bib83) 2012; 43
Ersoy (10.1016/j.bioflm.2024.100192_bib11) 2017; 20
Kang (10.1016/j.bioflm.2024.100192_bib48) 2022; 11
Singh (10.1016/j.bioflm.2024.100192_bib31) 2018; 46
Jeong (10.1016/j.bioflm.2024.100192_bib41) 2023
Indira (10.1016/j.bioflm.2024.100192_bib38) 2019; 9
Qin (10.1016/j.bioflm.2024.100192_bib87) 2022; 7
Brooks (10.1016/j.bioflm.2024.100192_bib44) 1997; 24
Tamma (10.1016/j.bioflm.2024.100192_bib80) 2012; 25
Mohamed (10.1016/j.bioflm.2024.100192_bib86) 2020; 26
Khan (10.1016/j.bioflm.2024.100192_bib30) 2023; 12
Lee (10.1016/j.bioflm.2024.100192_bib54) 2011; 13
Who (10.1016/j.bioflm.2024.100192_bib8) 2017
Briaud (10.1016/j.bioflm.2024.100192_bib15) 2019; 9
O'Brien (10.1016/j.bioflm.2024.100192_bib16) 2022; 16
Luo (10.1016/j.bioflm.2024.100192_bib56) 2017; 12
Khan (10.1016/j.bioflm.2024.100192_bib24) 2022; 14
Oura (10.1016/j.bioflm.2024.100192_bib55) 2015; 81
Jeong (10.1016/j.bioflm.2024.100192_bib64) 2023
Sriramulu (10.1016/j.bioflm.2024.100192_bib42) 2005; 54
Murray (10.1016/j.bioflm.2024.100192_bib6) 2022; 399
Larsson (10.1016/j.bioflm.2024.100192_bib1) 2022; 20
Fisher (10.1016/j.bioflm.2024.100192_bib3) 2022; 20
Rather (10.1016/j.bioflm.2024.100192_bib21) 2021; 61
Kumar (10.1016/j.bioflm.2024.100192_bib60) 2017; 307
Asokan (10.1016/j.bioflm.2024.100192_bib7) 2019; 34
Singh (10.1016/j.bioflm.2024.100192_bib32) 2022; 10
Khan (10.1016/j.bioflm.2024.100192_bib47) 2019; 17
Tuon (10.1016/j.bioflm.2024.100192_bib88) 2022; 11
Gow (10.1016/j.bioflm.2024.100192_bib2) 2022; 13
Garcia Maset (10.1016/j.bioflm.2024.100192_bib12) 2022; 14
Hannauer (10.1016/j.bioflm.2024.100192_bib67) 2012; 586
Khan (10.1016/j.bioflm.2024.100192_bib50) 2020; 104
Kumari (10.1016/j.bioflm.2024.100192_bib69) 2017; 24
Jeong (10.1016/j.bioflm.2024.100192_bib34) 2022; 20
Highmore (10.1016/j.bioflm.2024.100192_bib61) 2022; 8
Tyers (10.1016/j.bioflm.2024.100192_bib81) 2019; 17
Baldan (10.1016/j.bioflm.2024.100192_bib13) 2014; 9
Who (10.1016/j.bioflm.2024.100192_bib9) 2022
Fu (10.1016/j.bioflm.2024.100192_bib52) 2017; 2017
Jeong (10.1016/j.bioflm.2024.100192_bib63) 2023
Saravanan (10.1016/j.bioflm.2024.100192_bib37) 2021; 264
Kumar (10.1016/j.bioflm.2024.100192_bib89) 2022; 170
Liu (10.1016/j.bioflm.2024.100192_bib23) 2016; 7
Furiga (10.1016/j.bioflm.2024.100192_bib51) 2015; 60
Tabassum (10.1016/j.bioflm.2024.100192_bib46) 2023
Tabassum (10.1016/j.bioflm.2024.100192_bib29) 2023; 21
Rather (10.1016/j.bioflm.2024.100192_bib66) 2021; 269
Benedict (10.1016/j.bioflm.2024.100192_bib4) 2019; 68
Kang (10.1016/j.bioflm.2024.100192_bib27) 2023
Khan (10.1016/j.bioflm.2024.100192_bib45) 2021; 19
Flemming (10.1016/j.bioflm.2024.100192_bib58) 2010; 8
Rani (10.1016/j.bioflm.2024.100192_bib40) 2021; 26
Stewart (10.1016/j.bioflm.2024.100192_bib76) 2002; 292
Saeki (10.1016/j.bioflm.2024.100192_bib79) 2021; 11
Kumar (10.1016/j.bioflm.2024.100192_bib82) 2010; 38
Dane (10.1016/j.bioflm.2024.100192_bib33) 2016; 6
Du (10.1016/j.bioflm.2024.100192_bib74) 2017; 7
Khan (10.1016/j.bioflm.2024.100192_bib62) 2020; 46
Orazi (10.1016/j.bioflm.2024.100192_bib14) 2020
Khorsandi (10.1016/j.bioflm.2024.100192_bib28) 2021; 19
Naik (10.1016/j.bioflm.2024.100192_bib68) 2011; 62
References_xml – volume: 68
  start-page: 1791
  year: 2019
  end-page: 1797
  ident: bib4
  article-title: Estimation of direct healthcare costs of fungal diseases in the United States
  publication-title: Clin Infect Dis
  contributor:
    fullname: Benedict
– volume: 46
  start-page: 665
  year: 2020
  end-page: 688
  ident: bib62
  article-title: Treatment strategies targeting persister cell formation in bacterial pathogens
  publication-title: Crit Rev Microbiol
  contributor:
    fullname: Khan
– volume: 38
  start-page: 1651
  year: 2010
  end-page: 1664
  ident: bib82
  article-title: A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study
  publication-title: Crit Care Med
  contributor:
    fullname: Kumar
– volume: 2
  start-page: 95
  year: 2004
  end-page: 108
  ident: bib20
  article-title: Bacterial biofilms: from the natural environment to infectious diseases
  publication-title: Nat Rev Microbiol
  contributor:
    fullname: Stoodley
– volume: 17
  year: 2019
  ident: bib47
  article-title: Fucoidan-stabilized gold nanoparticle-mediated biofilm inhibition, attenuation of virulence and motility properties in
  publication-title: Mar Drugs
  contributor:
    fullname: Khan
– volume: 6
  start-page: 4180
  year: 2014
  end-page: 14184
  ident: bib72
  article-title: Suppression of nanoparticle cytotoxicity approaching
  publication-title: Nanoscale
  contributor:
    fullname: Kim
– volume: 24
  start-page: 4645
  year: 2017
  end-page: 4654
  ident: bib69
  article-title: Biogenic synthesis of silver nanoparticle by using secondary metabolites from
  publication-title: Environ Sci Pollut Res
  contributor:
    fullname: Singh
– volume: 34
  start-page: 184
  year: 2019
  end-page: 193
  ident: bib7
  article-title: WHO global priority pathogens list: a bibliometric analysis of medline-pubMed for knowledge mobilization to infection prevention and control practices in Bahrain
  publication-title: Oman Med J
  contributor:
    fullname: Asokan
– volume: 19
  start-page: 601
  year: 2021
  ident: bib45
  article-title: Phloroglucinol-gold and -zinc oxide nanoparticles: antibiofilm and antivirulence activities towards
  publication-title: Mar Drugs
  contributor:
    fullname: Khan
– volume: 20
  start-page: 173
  year: 2017
  end-page: 181
  ident: bib11
  article-title: Correcting a fundamental flaw in the paradigm for antimicrobial susceptibility testing
  publication-title: EBioMedicine
  contributor:
    fullname: Ersoy
– volume: 20
  start-page: 557
  year: 2022
  end-page: 571
  ident: bib3
  article-title: Tackling the emerging threat of antifungal resistance to human health
  publication-title: Nat Rev Microbiol
  contributor:
    fullname: Fisher
– volume: 586
  start-page: 96
  year: 2012
  end-page: 101
  ident: bib67
  article-title: Biosynthesis of the pyoverdine siderophore of
  publication-title: FEBS Lett
  contributor:
    fullname: Hannauer
– volume: 19
  start-page: 1299
  year: 2021
  end-page: 1323
  ident: bib28
  article-title: Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities
  publication-title: Expert Rev Anti Infect Ther
  contributor:
    fullname: Khorsandi
– volume: 21
  start-page: 148
  year: 2023
  ident: bib25
  article-title: Therapeutic applications of nanobiotechnology
  publication-title: J Nanobiotechnol
  contributor:
    fullname: Dutt
– volume: 8
  start-page: 623
  year: 2010
  end-page: 633
  ident: bib58
  article-title: The biofilm matrix
  publication-title: Nat Rev Microbiol
  contributor:
    fullname: Wingender
– volume: 98
  start-page: 50
  year: 2016
  end-page: 56
  ident: bib75
  article-title: Biofilm inhibitory effect of chlorhexidine conjugated gold nanoparticles against
  publication-title: Microb Pathog
  contributor:
    fullname: Ahmed
– volume: 46
  start-page: 886
  year: 2018
  end-page: 899
  ident: bib31
  article-title: Anti-biofilm effects of gold and silver nanoparticles synthesized by the
  publication-title: Artif Cells Nanomed Biotechnol
  contributor:
    fullname: Singh
– volume: 170
  year: 2022
  ident: bib89
  article-title: Superior inhibition of virulence and biofilm formation of
  publication-title: Microb Pathog
  contributor:
    fullname: Singh
– volume: 8
  start-page: 68
  year: 2022
  ident: bib61
  article-title: Translational challenges and opportunities in biofilm science: a BRIEF for the future
  publication-title: NPJ Biofilms Microbiomes
  contributor:
    fullname: Highmore
– volume: 20
  start-page: 257
  year: 2022
  end-page: 269
  ident: bib1
  article-title: Antibiotic resistance in the environment
  publication-title: Nat Rev Microbiol
  contributor:
    fullname: Flach
– year: October 2022
  ident: bib9
  article-title: WHO fungal priority pathogens list to guide research, development and public health action
  contributor:
    fullname: Who
– volume: 13
  start-page: 62
  year: 2011
  end-page: 73
  ident: bib54
  article-title: 3-indolylacetonitrile decreases
  publication-title: Environ Microbiol
  contributor:
    fullname: Lee
– volume: 21
  year: 2023
  ident: bib29
  article-title: Inhibition of polymicrobial biofilms of
  publication-title: Mar Drugs
  contributor:
    fullname: Tabassum
– volume: 9
  year: 2014
  ident: bib13
  article-title: Adaptation of
  publication-title: PLoS One
  contributor:
    fullname: Baldan
– volume: 26
  start-page: 1142
  year: 2021
  ident: bib40
  article-title: Microorganisms: a potential source of bioactive molecules for antioxidant applications
  publication-title: Molecules
  contributor:
    fullname: Rani
– year: 2023
  ident: bib41
  article-title: virulence attenuation by inhibiting siderophore functions
  publication-title: Appl Microbiol Biotechnol
  contributor:
    fullname: Jeong
– year: 2023
  ident: bib64
  article-title: pH-responsive polymeric nanomaterials for the treatment of oral biofilm infections
  publication-title: Colloids Surf B Biointerfaces
  contributor:
    fullname: Jeong
– volume: 3
  start-page: 1101
  year: 2008
  end-page: 1108
  ident: bib57
  article-title: Analyzing real-time PCR data by the comparative C(T) method
  publication-title: Nat Protoc
  contributor:
    fullname: Livak
– volume: 248
  year: 2020
  ident: bib71
  article-title: Green synthesis of silver nanoparticles using
  publication-title: Mater Chem Phys
  contributor:
    fullname: Dridi
– volume: 14
  start-page: 32855
  year: 2022
  end-page: 32868
  ident: bib12
  article-title: Evaluation of the antimicrobial activity in host-mimicking media and
  publication-title: ACS Appl Mater Interfaces
  contributor:
    fullname: Garcia Maset
– volume: 264
  year: 2021
  ident: bib37
  article-title: A review on biosynthesis of metal nanoparticles and its environmental applications
  publication-title: Chemosphere
  contributor:
    fullname: Saravanan
– volume: 20
  start-page: 621
  year: 2022
  end-page: 635
  ident: bib17
  article-title: Tolerance and resistance of microbial biofilms
  publication-title: Nat Rev Microbiol
  contributor:
    fullname: Ciofu
– volume: 9
  year: 2019
  ident: bib15
  article-title: Coexistence with
  publication-title: Sci Rep
  contributor:
    fullname: Briaud
– volume: 52
  start-page: 1701
  year: 2021
  end-page: 1718
  ident: bib18
  article-title: Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies
  publication-title: Braz J Microbiol
  contributor:
    fullname: Mandal
– volume: 13
  start-page: 5352
  year: 2022
  ident: bib2
  article-title: The importance of antimicrobial resistance in medical mycology
  publication-title: Nat Commun
  contributor:
    fullname: Gow
– year: March 2017
  ident: bib8
  article-title: WHO publishes list of bacteria for which new antibiotics are urgently needed
  contributor:
    fullname: Who
– volume: 14
  start-page: 14824
  year: 2022
  end-page: 14857
  ident: bib24
  article-title: Retrospective analysis of the key molecules involved in the green synthesis of nanoparticles
  publication-title: Nanoscale
  contributor:
    fullname: Khan
– year: 2023
  ident: bib27
  article-title: Inhibition of biofilm and virulence properties of pathogenic bacteria by silver and gold nanoparticles synthesized from
  publication-title: ACS Omega
  contributor:
    fullname: Kang
– volume: 10
  start-page: 628
  year: 2022
  ident: bib32
  article-title: Antibacterial effect of silver nanoparticles is stronger if the production host and the targeted pathogen are closely related
  publication-title: Biomedicines
  contributor:
    fullname: Mijakovic
– volume: 81
  start-page: 2808
  year: 2015
  end-page: 2818
  ident: bib55
  article-title: Inhibition of
  publication-title: Appl Environ Microbiol
  contributor:
    fullname: Oura
– volume: 7
  year: 2016
  ident: bib23
  article-title: Interspecific bacterial interactions are reflected in multispecies biofilm spatial organization
  publication-title: Front Microbiol
  contributor:
    fullname: Liu
– volume: 54
  start-page: 667
  year: 2005
  end-page: 676
  ident: bib42
  article-title: Microcolony formation: a novel biofilm model of
  publication-title: J Med Microbiol
  contributor:
    fullname: Sriramulu
– volume: 7
  start-page: 41
  year: 2017
  ident: bib74
  article-title: Human salivary protein histatin 5 has potent bactericidal activity against ESKAPE pathogens
  publication-title: Front Cell Infect Microbiol
  contributor:
    fullname: Du
– volume: 62
  start-page: 409
  year: 2011
  end-page: 414
  ident: bib68
  article-title: Lead-enhanced siderophore production and alteration in cell morphology in a Pb-resistant
  publication-title: Curr Microbiol
  contributor:
    fullname: Dubey
– volume: 203
  start-page: 4755
  year: 2021
  end-page: 4776
  ident: bib39
  article-title: Therapeutic applications and biological activities of bacterial bioactive extracts
  publication-title: Arch Microbiol
  contributor:
    fullname: Abdelghani
– volume: 12
  year: 2022
  ident: bib77
  article-title: Antibiofilm activities of biogenic silver nanoparticles against
  publication-title: Front Microbiol
  contributor:
    fullname: Ahamad
– volume: 169
  start-page: 888
  year: 2014
  end-page: 896
  ident: bib53
  article-title: ZnO nanoparticles inhibit
  publication-title: Microbiol Res
  contributor:
    fullname: Lee
– volume: 11
  start-page: 1524
  year: 2022
  ident: bib48
  article-title: Antibiofilm and antivirulence activities of gold and zinc oxide nanoparticles synthesized from Kimchi-isolated
  publication-title: Antibiotics
  contributor:
    fullname: Kang
– year: 2023
  ident: bib63
  article-title: Controlling biofilm and virulence properties of Gram-positive bacteria by targeting wall teichoic acid and lipoteichoic acid
  publication-title: Int J Antimicrob Agents
  contributor:
    fullname: Jeong
– start-page: 1
  year: 2023
  end-page: 29
  ident: bib78
  article-title: Natural and synthetic molecules with potential to enhance biofilm formation and virulence properties in
  publication-title: Crit Rev Microbiol
  contributor:
    fullname: Jeong
– volume: 9
  start-page: 306
  year: 2019
  ident: bib38
  article-title: Bioactive molecules of probiotic bacteria and their mechanism of action: a review
  publication-title: 3 Biotech
  contributor:
    fullname: Indira
– volume: 12
  year: 2023
  ident: bib30
  article-title: Inhibition of mixed biofilms of
  publication-title: Antibiotics
  contributor:
    fullname: Khan
– volume: 11
  year: 2022
  ident: bib88
  article-title: Pathogenesis of the
  publication-title: Pathogens
  contributor:
    fullname: Tuon
– volume: 17
  start-page: 141
  year: 2019
  end-page: 155
  ident: bib81
  article-title: Drug combinations: a strategy to extend the life of antibiotics in the 21st century
  publication-title: Nat Rev Microbiol
  contributor:
    fullname: Wright
– volume: 43
  start-page: 938
  year: 2012
  end-page: 945
  ident: bib83
  article-title: Bactericidal antibiotic-phytochemical combinations against methicillin resistant
  publication-title: Braz J Microbiol
  contributor:
    fullname: Lim
– volume: 7
  start-page: 199
  year: 2022
  ident: bib87
  article-title: : pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics
  publication-title: Signal Transduct Targeted Ther
  contributor:
    fullname: Qin
– volume: 12
  start-page: 130
  year: 2022
  ident: bib35
  article-title: A review of microbial mediated iron nanoparticles (IONPs) and its biomedical applications
  publication-title: Nanomaterials
  contributor:
    fullname: Nadeem
– volume: 76
  start-page: 255
  year: 2022
  end-page: 262
  ident: bib5
  article-title: Increased deaths from fungal infections during the coronavirus disease 2019 pandemic—national vital statistics system, United States, January 2020–December 2021
  publication-title: Clin Infect Dis
  contributor:
    fullname: Gold
– volume: 8
  start-page: 76
  year: 2019
  ident: bib22
  article-title: Antibiotics versus biofilm: an emerging battleground in microbial communities
  publication-title: Antimicrob Resist Infect Control
  contributor:
    fullname: Khan
– start-page: 202
  year: 2020
  ident: bib14
  article-title: PA14 enhances the efficacy of norfloxacin against
  publication-title: J Bacteriol
  contributor:
    fullname: O'Toole
– year: 2023
  ident: bib65
  article-title: Alteration of oral microbial biofilms by sweeteners
  publication-title: Biofilms
  contributor:
    fullname: Jeong
– volume: 25
  start-page: 257
  year: 2017
  end-page: 266
  ident: bib59
  article-title: The peculiar functions of the bacterial extracellular matrix
  publication-title: Trends Microbiol
  contributor:
    fullname: Kovács
– volume: 20
  start-page: 527
  year: 2022
  ident: bib34
  article-title: Marine-bioinspired nanoparticles as potential drugs for multiple biological roles
  publication-title: Mar Drugs
  contributor:
    fullname: Jeong
– volume: 68
  start-page: 807
  year: 2017
  end-page: 813
  ident: bib43
  article-title: Artificial saliva and its use in biological experiments
  publication-title: J Physiol Pharmacol
  contributor:
    fullname: J
– volume: 6
  start-page: 8503
  year: 2016
  end-page: 8510
  ident: bib33
  article-title: Pyoverdin mediated sunlight induced green synthesis of silver nanoparticles
  publication-title: RSC Adv
  contributor:
    fullname: Dane
– volume: 269
  year: 2021
  ident: bib66
  article-title: Inhibition of biofilm and quorum sensing-regulated virulence factors in
  publication-title: J Ethnopharmacol
  contributor:
    fullname: Mandal
– volume: 211
  year: 2022
  ident: bib49
  article-title: Inhibitory activities of phloroglucinol-chitosan nanoparticles on mono- and dual-species biofilms of
  publication-title: Colloids Surf B Biointerfaces
  contributor:
    fullname: Khan
– volume: 399
  start-page: 629
  year: 2022
  end-page: 655
  ident: bib6
  article-title: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
  publication-title: Lancet
  contributor:
    fullname: Murray
– volume: 25
  start-page: 450
  year: 2012
  end-page: 470
  ident: bib80
  article-title: Combination therapy for treatment of infections with Gram-negative bacteria
  publication-title: Clin Microbiol Rev
  contributor:
    fullname: Maragakis
– volume: 16
  start-page: 1694
  year: 2022
  end-page: 1704
  ident: bib16
  article-title: Decreased efficacy of antimicrobial agents in a polymicrobial environment
  publication-title: ISME J
  contributor:
    fullname: Welch
– volume: 56
  year: 2018
  ident: bib10
  article-title: CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests
  publication-title: J Clin Microbiol
  contributor:
    fullname: Humphries
– volume: 24
  start-page: 203
  year: 1997
  end-page: 206
  ident: bib44
  article-title: A simple artificial urine for the growth of urinary pathogens
  publication-title: Lett Appl Microbiol
  contributor:
    fullname: Keevil
– volume: 60
  start-page: 1676
  year: 2015
  end-page: 1686
  ident: bib51
  article-title: Impairment of
  publication-title: Antimicrob Agents Chemother
  contributor:
    fullname: Furiga
– volume: 12
  year: 2017
  ident: bib56
  article-title: Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances
  publication-title: PLoS One
  contributor:
    fullname: Luo
– volume: 292
  start-page: 107
  year: 2002
  end-page: 113
  ident: bib76
  article-title: Mechanisms of antibiotic resistance in bacterial biofilms
  publication-title: Int J Med Microbiol
  contributor:
    fullname: Stewart
– volume: 47
  start-page: 699
  year: 2021
  end-page: 727
  ident: bib84
  article-title: Mixed biofilms of pathogenic
  publication-title: Crit Rev Microbiol
  contributor:
    fullname: Khan
– volume: 53
  start-page: 115
  year: 2023
  end-page: 136
  ident: bib85
  article-title: Surface adherence and vacuolar internalization of bacterial pathogens to the
  publication-title: J Adv Res
  contributor:
    fullname: Khan
– volume: 159
  start-page: 18
  year: 2019
  end-page: 25
  ident: bib36
  article-title: Revisiting the mechanistic pathways for bacterial mediated synthesis of noble metal nanoparticles
  publication-title: J Microbiol Methods
  contributor:
    fullname: Ali
– year: 2023
  ident: bib46
  article-title: Treatment of
  publication-title: Microb Pathog
  contributor:
    fullname: Tabassum
– volume: 300
  year: 2022
  ident: bib26
  article-title: Ecofriendly phytofabrication of silver nanoparticles using aqueous extract of
  publication-title: Chemosphere
  contributor:
    fullname: Rather
– volume: 4
  start-page: 274
  year: 2018
  end-page: 288
  ident: bib19
  article-title: Extracellular polymeric substances, a key element in understanding biofilm phenotype
  publication-title: AIMS Microbiol
  contributor:
    fullname: Di Martino
– volume: 26
  start-page: 1410
  year: 2020
  end-page: 1420
  ident: bib86
  article-title: Combination of silver nanoparticles and vancomycin to overcome antibiotic resistance in planktonic/biofilm cell from clinical and animal source
  publication-title: Microb Drug Resist
  contributor:
    fullname: Mohamed
– volume: 307
  start-page: 481
  year: 2017
  end-page: 489
  ident: bib60
  article-title: Biofilms: survival and defense strategy for pathogens
  publication-title: Int J Med Microbiol
  contributor:
    fullname: Kumar
– volume: 2017
  year: 2017
  ident: bib52
  article-title: Inhibition of
  publication-title: BioMed Res Int
  contributor:
    fullname: Fu
– volume: 104
  start-page: 799
  year: 2020
  end-page: 816
  ident: bib50
  article-title: Streptomycin mediated biofilm inhibition and suppression of virulence properties in
  publication-title: Appl Microbiol Biotechnol
  contributor:
    fullname: Khan
– volume: 669
  start-page: 71
  year: 2017
  end-page: 79
  ident: bib70
  article-title: Physiochemical charge stabilization of silver nanoparticles and its antibacterial applications
  publication-title: Chem Phys Lett
  contributor:
    fullname: Vanitha
– volume: 7
  year: 2021
  ident: bib73
  article-title: Envisaging antifungal potential of histatin 5: a physiological salivary peptide
  publication-title: J Fungi
  contributor:
    fullname: Sharma
– volume: 11
  year: 2021
  ident: bib79
  article-title: Subinhibitory concentrations of biogenic silver nanoparticles affect motility and biofilm formation in
  publication-title: Front Cell Infect Microbiol
  contributor:
    fullname: Saeki
– volume: 61
  start-page: 380
  year: 2021
  end-page: 395
  ident: bib21
  article-title: Microbial biofilm: a matter of grave concern for human health and food industry
  publication-title: J Basic Microbiol
  contributor:
    fullname: Rather
– volume: 11
  start-page: 1524
  issue: 11
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib48
  article-title: Antibiofilm and antivirulence activities of gold and zinc oxide nanoparticles synthesized from Kimchi-isolated Leuconostoc sp. strain C2
  publication-title: Antibiotics
  doi: 10.3390/antibiotics11111524
  contributor:
    fullname: Kang
– volume: 76
  start-page: 255
  issue: 3
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib5
  article-title: Increased deaths from fungal infections during the coronavirus disease 2019 pandemic—national vital statistics system, United States, January 2020–December 2021
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciac489
  contributor:
    fullname: Gold
– volume: 61
  start-page: 380
  issue: 5
  year: 2021
  ident: 10.1016/j.bioflm.2024.100192_bib21
  article-title: Microbial biofilm: a matter of grave concern for human health and food industry
  publication-title: J Basic Microbiol
  doi: 10.1002/jobm.202000678
  contributor:
    fullname: Rather
– volume: 9
  issue: 3
  year: 2014
  ident: 10.1016/j.bioflm.2024.100192_bib13
  article-title: Adaptation of Pseudomonas aeruginosa in cystic fibrosis airways influences virulence of Staphylococcus aureus in vitro and murine models of co-infection
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0089614
  contributor:
    fullname: Baldan
– volume: 56
  issue: 4
  year: 2018
  ident: 10.1016/j.bioflm.2024.100192_bib10
  article-title: CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.01934-17
  contributor:
    fullname: Humphries
– volume: 203
  start-page: 4755
  issue: 8
  year: 2021
  ident: 10.1016/j.bioflm.2024.100192_bib39
  article-title: Therapeutic applications and biological activities of bacterial bioactive extracts
  publication-title: Arch Microbiol
  doi: 10.1007/s00203-021-02505-1
  contributor:
    fullname: Abdelghani
– volume: 52
  start-page: 1701
  issue: 4
  year: 2021
  ident: 10.1016/j.bioflm.2024.100192_bib18
  article-title: Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies
  publication-title: Braz J Microbiol
  doi: 10.1007/s42770-021-00624-x
  contributor:
    fullname: Rather
– volume: 12
  issue: 4
  year: 2017
  ident: 10.1016/j.bioflm.2024.100192_bib56
  article-title: Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0176883
  contributor:
    fullname: Luo
– volume: 248
  year: 2020
  ident: 10.1016/j.bioflm.2024.100192_bib71
  article-title: Green synthesis of silver nanoparticles using Melia azedarach leaf extract and their antifungal activities: in vitro and in vivo
  publication-title: Mater Chem Phys
  doi: 10.1016/j.matchemphys.2020.122898
  contributor:
    fullname: Jebril
– volume: 46
  start-page: 886
  issue: 3
  year: 2018
  ident: 10.1016/j.bioflm.2024.100192_bib31
  article-title: Anti-biofilm effects of gold and silver nanoparticles synthesized by the Rhodiola rosea rhizome extracts
  publication-title: Artif Cells Nanomed Biotechnol
  doi: 10.1080/21691401.2018.1518909
  contributor:
    fullname: Singh
– volume: 20
  start-page: 173
  year: 2017
  ident: 10.1016/j.bioflm.2024.100192_bib11
  article-title: Correcting a fundamental flaw in the paradigm for antimicrobial susceptibility testing
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2017.05.026
  contributor:
    fullname: Ersoy
– volume: 20
  start-page: 527
  issue: 8
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib34
  article-title: Marine-bioinspired nanoparticles as potential drugs for multiple biological roles
  publication-title: Mar Drugs
  doi: 10.3390/md20080527
  contributor:
    fullname: Jeong
– volume: 8
  start-page: 623
  issue: 9
  year: 2010
  ident: 10.1016/j.bioflm.2024.100192_bib58
  article-title: The biofilm matrix
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro2415
  contributor:
    fullname: Flemming
– volume: 19
  start-page: 1299
  issue: 10
  year: 2021
  ident: 10.1016/j.bioflm.2024.100192_bib28
  article-title: Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities
  publication-title: Expert Rev Anti Infect Ther
  doi: 10.1080/14787210.2021.1908125
  contributor:
    fullname: Khorsandi
– volume: 38
  start-page: 1651
  issue: 8
  year: 2010
  ident: 10.1016/j.bioflm.2024.100192_bib82
  article-title: A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0b013e3181e96b91
  contributor:
    fullname: Kumar
– start-page: 1
  year: 2023
  ident: 10.1016/j.bioflm.2024.100192_bib78
  article-title: Natural and synthetic molecules with potential to enhance biofilm formation and virulence properties in Pseudomonas aeruginosa
  publication-title: Crit Rev Microbiol
  doi: 10.1080/1040841X.2023.2282459
  contributor:
    fullname: Jeong
– volume: 159
  start-page: 18
  year: 2019
  ident: 10.1016/j.bioflm.2024.100192_bib36
  article-title: Revisiting the mechanistic pathways for bacterial mediated synthesis of noble metal nanoparticles
  publication-title: J Microbiol Methods
  doi: 10.1016/j.mimet.2019.02.010
  contributor:
    fullname: Ali
– volume: 24
  start-page: 4645
  year: 2017
  ident: 10.1016/j.bioflm.2024.100192_bib69
  article-title: Biogenic synthesis of silver nanoparticle by using secondary metabolites from Pseudomonas aeruginosa DM1 and its anti-algal effect on Chlorella vulgaris and Chlorella pyrenoidosa
  publication-title: Environ Sci Pollut Res
  doi: 10.1007/s11356-016-8170-3
  contributor:
    fullname: Kumari
– volume: 399
  start-page: 629
  issue: 10325
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib6
  article-title: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)02724-0
  contributor:
    fullname: Murray
– volume: 8
  start-page: 76
  issue: 1
  year: 2019
  ident: 10.1016/j.bioflm.2024.100192_bib22
  article-title: Antibiotics versus biofilm: an emerging battleground in microbial communities
  publication-title: Antimicrob Resist Infect Control
  doi: 10.1186/s13756-019-0533-3
  contributor:
    fullname: Sharma
– volume: 586
  start-page: 96
  issue: 1
  year: 2012
  ident: 10.1016/j.bioflm.2024.100192_bib67
  article-title: Biosynthesis of the pyoverdine siderophore of Pseudomonas aeruginosa involves precursors with a myristic or a myristoleic acid chain
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2011.12.004
  contributor:
    fullname: Hannauer
– volume: 669
  start-page: 71
  year: 2017
  ident: 10.1016/j.bioflm.2024.100192_bib70
  article-title: Physiochemical charge stabilization of silver nanoparticles and its antibacterial applications
  publication-title: Chem Phys Lett
  doi: 10.1016/j.cplett.2016.11.037
  contributor:
    fullname: Vanitha
– volume: 7
  issue: 12
  year: 2021
  ident: 10.1016/j.bioflm.2024.100192_bib73
  article-title: Envisaging antifungal potential of histatin 5: a physiological salivary peptide
  publication-title: J Fungi
  doi: 10.3390/jof7121070
  contributor:
    fullname: Sharma
– volume: 68
  start-page: 807
  issue: 6
  year: 2017
  ident: 10.1016/j.bioflm.2024.100192_bib43
  article-title: Artificial saliva and its use in biological experiments
  publication-title: J Physiol Pharmacol
  contributor:
    fullname: J
– volume: 269
  year: 2021
  ident: 10.1016/j.bioflm.2024.100192_bib66
  article-title: Inhibition of biofilm and quorum sensing-regulated virulence factors in Pseudomonas aeruginosa by Cuphea carthagenensis (Jacq.) J. F. Macbr. leaf extract: an in vitro study
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2020.113699
  contributor:
    fullname: Rather
– volume: 21
  start-page: 148
  issue: 1
  year: 2023
  ident: 10.1016/j.bioflm.2024.100192_bib25
  article-title: Therapeutic applications of nanobiotechnology
  publication-title: J Nanobiotechnol
  doi: 10.1186/s12951-023-01909-z
  contributor:
    fullname: Dutt
– volume: 81
  start-page: 2808
  issue: 8
  year: 2015
  ident: 10.1016/j.bioflm.2024.100192_bib55
  article-title: Inhibition of Pseudomonas aeruginosa swarming motility by 1-naphthol and other bicyclic compounds bearing hydroxyl groups
  publication-title: Appl Environ Microbiol
  doi: 10.1128/AEM.04220-14
  contributor:
    fullname: Oura
– volume: 10
  start-page: 628
  issue: 3
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib32
  article-title: Antibacterial effect of silver nanoparticles is stronger if the production host and the targeted pathogen are closely related
  publication-title: Biomedicines
  doi: 10.3390/biomedicines10030628
  contributor:
    fullname: Singh
– volume: 3
  start-page: 1101
  issue: 6
  year: 2008
  ident: 10.1016/j.bioflm.2024.100192_bib57
  article-title: Analyzing real-time PCR data by the comparative C(T) method
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2008.73
  contributor:
    fullname: Schmittgen
– volume: 53
  start-page: 115
  year: 2023
  ident: 10.1016/j.bioflm.2024.100192_bib85
  article-title: Surface adherence and vacuolar internalization of bacterial pathogens to the Candida spp. cells: mechanism of persistence and propagation
  publication-title: J Adv Res
  doi: 10.1016/j.jare.2022.12.013
  contributor:
    fullname: Khan
– volume: 46
  start-page: 665
  issue: 6
  year: 2020
  ident: 10.1016/j.bioflm.2024.100192_bib62
  article-title: Treatment strategies targeting persister cell formation in bacterial pathogens
  publication-title: Crit Rev Microbiol
  doi: 10.1080/1040841X.2020.1822278
  contributor:
    fullname: Khan
– volume: 11
  issue: 3
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib88
  article-title: Pathogenesis of the Pseudomonas aeruginosa biofilm: a review
  publication-title: Pathogens
  doi: 10.3390/pathogens11030300
  contributor:
    fullname: Tuon
– volume: 68
  start-page: 1791
  issue: 11
  year: 2019
  ident: 10.1016/j.bioflm.2024.100192_bib4
  article-title: Estimation of direct healthcare costs of fungal diseases in the United States
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciy776
  contributor:
    fullname: Benedict
– volume: 25
  start-page: 450
  issue: 3
  year: 2012
  ident: 10.1016/j.bioflm.2024.100192_bib80
  article-title: Combination therapy for treatment of infections with Gram-negative bacteria
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.05041-11
  contributor:
    fullname: Tamma
– volume: 9
  issue: 1
  year: 2019
  ident: 10.1016/j.bioflm.2024.100192_bib15
  article-title: Coexistence with Pseudomonas aeruginosa alters Staphylococcus aureus transcriptome, antibiotic resistance and internalization into epithelial cells
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-52975-z
  contributor:
    fullname: Briaud
– year: 2023
  ident: 10.1016/j.bioflm.2024.100192_bib65
  article-title: Alteration of oral microbial biofilms by sweeteners
  publication-title: Biofilms
  contributor:
    fullname: Jeong
– volume: 62
  start-page: 409
  issue: 2
  year: 2011
  ident: 10.1016/j.bioflm.2024.100192_bib68
  article-title: Lead-enhanced siderophore production and alteration in cell morphology in a Pb-resistant Pseudomonas aeruginosa strain 4EA
  publication-title: Curr Microbiol
  doi: 10.1007/s00284-010-9722-2
  contributor:
    fullname: Naik
– volume: 26
  start-page: 1410
  issue: 11
  year: 2020
  ident: 10.1016/j.bioflm.2024.100192_bib86
  article-title: Combination of silver nanoparticles and vancomycin to overcome antibiotic resistance in planktonic/biofilm cell from clinical and animal source
  publication-title: Microb Drug Resist
  doi: 10.1089/mdr.2020.0089
  contributor:
    fullname: Mohamed
– volume: 300
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib26
  article-title: Ecofriendly phytofabrication of silver nanoparticles using aqueous extract of Cuphea carthagenensis and their antioxidant potential and antibacterial activity against clinically important human pathogens
  publication-title: Chemosphere
  doi: 10.1016/j.chemosphere.2022.134497
  contributor:
    fullname: Rather
– volume: 7
  start-page: 199
  issue: 1
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib87
  article-title: Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics
  publication-title: Signal Transduct Targeted Ther
  doi: 10.1038/s41392-022-01056-1
  contributor:
    fullname: Qin
– volume: 307
  start-page: 481
  issue: 8
  year: 2017
  ident: 10.1016/j.bioflm.2024.100192_bib60
  article-title: Biofilms: survival and defense strategy for pathogens
  publication-title: Int J Med Microbiol
  doi: 10.1016/j.ijmm.2017.09.016
  contributor:
    fullname: Kumar
– year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib9
  contributor:
    fullname: Who
– year: 2023
  ident: 10.1016/j.bioflm.2024.100192_bib27
  article-title: Inhibition of biofilm and virulence properties of pathogenic bacteria by silver and gold nanoparticles synthesized from Lactiplantibacillus sp. strain C1
  publication-title: ACS Omega
  doi: 10.1021/acsomega.2c06789
  contributor:
    fullname: Kang
– volume: 9
  start-page: 306
  issue: 8
  year: 2019
  ident: 10.1016/j.bioflm.2024.100192_bib38
  article-title: Bioactive molecules of probiotic bacteria and their mechanism of action: a review
  publication-title: 3 Biotech
  doi: 10.1007/s13205-019-1841-2
  contributor:
    fullname: Indira
– volume: 20
  start-page: 621
  issue: 10
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib17
  article-title: Tolerance and resistance of microbial biofilms
  publication-title: Nat Rev Microbiol
  doi: 10.1038/s41579-022-00682-4
  contributor:
    fullname: Ciofu
– volume: 12
  issue: 4
  year: 2023
  ident: 10.1016/j.bioflm.2024.100192_bib30
  article-title: Inhibition of mixed biofilms of Candida albicans and Staphylococcus aureus by β-caryophyllene-gold nanoparticles
  publication-title: Antibiotics
  doi: 10.3390/antibiotics12040726
  contributor:
    fullname: Khan
– volume: 7
  start-page: 41
  year: 2017
  ident: 10.1016/j.bioflm.2024.100192_bib74
  article-title: Human salivary protein histatin 5 has potent bactericidal activity against ESKAPE pathogens
  publication-title: Front Cell Infect Microbiol
  doi: 10.3389/fcimb.2017.00041
  contributor:
    fullname: Du
– start-page: 202
  issue: 18
  year: 2020
  ident: 10.1016/j.bioflm.2024.100192_bib14
  article-title: Pseudomonas aeruginosa PA14 enhances the efficacy of norfloxacin against Staphylococcus aureus newman biofilms
  publication-title: J Bacteriol
  contributor:
    fullname: Orazi
– volume: 13
  start-page: 5352
  issue: 1
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib2
  article-title: The importance of antimicrobial resistance in medical mycology
  publication-title: Nat Commun
  doi: 10.1038/s41467-022-32249-5
  contributor:
    fullname: Gow
– volume: 25
  start-page: 257
  issue: 4
  year: 2017
  ident: 10.1016/j.bioflm.2024.100192_bib59
  article-title: The peculiar functions of the bacterial extracellular matrix
  publication-title: Trends Microbiol
  doi: 10.1016/j.tim.2016.12.010
  contributor:
    fullname: Dragoš
– volume: 292
  start-page: 107
  issue: 2
  year: 2002
  ident: 10.1016/j.bioflm.2024.100192_bib76
  article-title: Mechanisms of antibiotic resistance in bacterial biofilms
  publication-title: Int J Med Microbiol
  doi: 10.1078/1438-4221-00196
  contributor:
    fullname: Stewart
– volume: 26
  start-page: 1142
  issue: 4
  year: 2021
  ident: 10.1016/j.bioflm.2024.100192_bib40
  article-title: Microorganisms: a potential source of bioactive molecules for antioxidant applications
  publication-title: Molecules
  doi: 10.3390/molecules26041142
  contributor:
    fullname: Rani
– volume: 20
  start-page: 557
  issue: 9
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib3
  article-title: Tackling the emerging threat of antifungal resistance to human health
  publication-title: Nat Rev Microbiol
  doi: 10.1038/s41579-022-00720-1
  contributor:
    fullname: Fisher
– volume: 34
  start-page: 184
  issue: 3
  year: 2019
  ident: 10.1016/j.bioflm.2024.100192_bib7
  article-title: WHO global priority pathogens list: a bibliometric analysis of medline-pubMed for knowledge mobilization to infection prevention and control practices in Bahrain
  publication-title: Oman Med J
  doi: 10.5001/omj.2019.37
  contributor:
    fullname: Asokan
– year: 2017
  ident: 10.1016/j.bioflm.2024.100192_bib8
  contributor:
    fullname: Who
– volume: 264
  year: 2021
  ident: 10.1016/j.bioflm.2024.100192_bib37
  article-title: A review on biosynthesis of metal nanoparticles and its environmental applications
  publication-title: Chemosphere
  doi: 10.1016/j.chemosphere.2020.128580
  contributor:
    fullname: Saravanan
– volume: 20
  start-page: 257
  issue: 5
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib1
  article-title: Antibiotic resistance in the environment
  publication-title: Nat Rev Microbiol
  doi: 10.1038/s41579-021-00649-x
  contributor:
    fullname: Larsson
– volume: 2017
  year: 2017
  ident: 10.1016/j.bioflm.2024.100192_bib52
  article-title: Inhibition of Pseudomonas aeruginosa biofilm formation by traditional Chinese medicinal herb Herba patriniae
  publication-title: BioMed Res Int
  doi: 10.1155/2017/9584703
  contributor:
    fullname: Fu
– volume: 4
  start-page: 274
  issue: 2
  year: 2018
  ident: 10.1016/j.bioflm.2024.100192_bib19
  article-title: Extracellular polymeric substances, a key element in understanding biofilm phenotype
  publication-title: AIMS Microbiol
  doi: 10.3934/microbiol.2018.2.274
  contributor:
    fullname: Di Martino
– volume: 169
  start-page: 888
  issue: 12
  year: 2014
  ident: 10.1016/j.bioflm.2024.100192_bib53
  article-title: ZnO nanoparticles inhibit Pseudomonas aeruginosa biofilm formation and virulence factor production
  publication-title: Microbiol Res
  doi: 10.1016/j.micres.2014.05.005
  contributor:
    fullname: Lee
– volume: 104
  start-page: 799
  issue: 2
  year: 2020
  ident: 10.1016/j.bioflm.2024.100192_bib50
  article-title: Streptomycin mediated biofilm inhibition and suppression of virulence properties in Pseudomonas aeruginosa PAO1
  publication-title: Appl Microbiol Biotechnol
  doi: 10.1007/s00253-019-10190-w
  contributor:
    fullname: Khan
– volume: 14
  start-page: 14824
  issue: 40
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib24
  article-title: Retrospective analysis of the key molecules involved in the green synthesis of nanoparticles
  publication-title: Nanoscale
  doi: 10.1039/D2NR03632K
  contributor:
    fullname: Khan
– volume: 21
  issue: 2
  year: 2023
  ident: 10.1016/j.bioflm.2024.100192_bib29
  article-title: Inhibition of polymicrobial biofilms of Candida albicans-Staphylococcus aureus/Streptococcus mutans by fucoidan-gold nanoparticles
  publication-title: Mar Drugs
  doi: 10.3390/md21020123
  contributor:
    fullname: Tabassum
– volume: 60
  start-page: 1676
  issue: 3
  year: 2015
  ident: 10.1016/j.bioflm.2024.100192_bib51
  article-title: Impairment of Pseudomonas aeruginosa biofilm resistance to antibiotics by combining the drugs with a new quorum-sensing inhibitor
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.02533-15
  contributor:
    fullname: Furiga
– year: 2023
  ident: 10.1016/j.bioflm.2024.100192_bib63
  article-title: Controlling biofilm and virulence properties of Gram-positive bacteria by targeting wall teichoic acid and lipoteichoic acid
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2023.106941
  contributor:
    fullname: Jeong
– volume: 17
  issue: 4
  year: 2019
  ident: 10.1016/j.bioflm.2024.100192_bib47
  article-title: Fucoidan-stabilized gold nanoparticle-mediated biofilm inhibition, attenuation of virulence and motility properties in Pseudomonas aeruginosa PAO1
  publication-title: Mar Drugs
  doi: 10.3390/md17040208
  contributor:
    fullname: Khan
– volume: 19
  start-page: 601
  issue: 11
  year: 2021
  ident: 10.1016/j.bioflm.2024.100192_bib45
  article-title: Phloroglucinol-gold and -zinc oxide nanoparticles: antibiofilm and antivirulence activities towards Pseudomonas aeruginosa PAO1
  publication-title: Mar Drugs
  doi: 10.3390/md19110601
  contributor:
    fullname: Khan
– volume: 12
  start-page: 130
  issue: 1
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib35
  article-title: A review of microbial mediated iron nanoparticles (IONPs) and its biomedical applications
  publication-title: Nanomaterials
  doi: 10.3390/nano12010130
  contributor:
    fullname: Nadeem
– volume: 12
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib77
  article-title: Antibiofilm activities of biogenic silver nanoparticles against Candida albicans
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2021.741493
  contributor:
    fullname: Ahamad
– volume: 16
  start-page: 1694
  issue: 7
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib16
  article-title: Decreased efficacy of antimicrobial agents in a polymicrobial environment
  publication-title: ISME J
  doi: 10.1038/s41396-022-01218-7
  contributor:
    fullname: O'Brien
– year: 2023
  ident: 10.1016/j.bioflm.2024.100192_bib46
  article-title: Treatment of Staphylococcus aureus and Candida albicans polymicrobial biofilms by phloroglucinol-gold nanoparticles
  publication-title: Microb Pathog
  doi: 10.1016/j.micpath.2023.106416
  contributor:
    fullname: Tabassum
– volume: 47
  start-page: 699
  issue: 6
  year: 2021
  ident: 10.1016/j.bioflm.2024.100192_bib84
  article-title: Mixed biofilms of pathogenic Candida-bacteria: regulation mechanisms and treatment strategies
  publication-title: Crit Rev Microbiol
  doi: 10.1080/1040841X.2021.1921696
  contributor:
    fullname: Khan
– volume: 14
  start-page: 32855
  issue: 29
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib12
  article-title: Evaluation of the antimicrobial activity in host-mimicking media and in vivo toxicity of antimicrobial polymers as functional mimics of AMPs
  publication-title: ACS Appl Mater Interfaces
  doi: 10.1021/acsami.2c05979
  contributor:
    fullname: Garcia Maset
– volume: 2
  start-page: 95
  issue: 2
  year: 2004
  ident: 10.1016/j.bioflm.2024.100192_bib20
  article-title: Bacterial biofilms: from the natural environment to infectious diseases
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro821
  contributor:
    fullname: Hall-Stoodley
– volume: 13
  start-page: 62
  issue: 1
  year: 2011
  ident: 10.1016/j.bioflm.2024.100192_bib54
  article-title: 3-indolylacetonitrile decreases Escherichia coli O157:H7 biofilm formation and Pseudomonas aeruginosa virulence
  publication-title: Environ Microbiol
  doi: 10.1111/j.1462-2920.2010.02308.x
  contributor:
    fullname: Lee
– volume: 6
  start-page: 8503
  issue: 10
  year: 2016
  ident: 10.1016/j.bioflm.2024.100192_bib33
  article-title: Pyoverdin mediated sunlight induced green synthesis of silver nanoparticles
  publication-title: RSC Adv
  doi: 10.1039/C5RA20856D
  contributor:
    fullname: Dane
– year: 2023
  ident: 10.1016/j.bioflm.2024.100192_bib41
  article-title: Pseudomonas aeruginosa virulence attenuation by inhibiting siderophore functions
  publication-title: Appl Microbiol Biotechnol
  doi: 10.1007/s00253-022-12347-6
  contributor:
    fullname: Jeong
– volume: 43
  start-page: 938
  issue: 3
  year: 2012
  ident: 10.1016/j.bioflm.2024.100192_bib83
  article-title: Bactericidal antibiotic-phytochemical combinations against methicillin resistant Staphylococcus aureus
  publication-title: Braz J Microbiol
  doi: 10.1590/S1517-83822012000300013
  contributor:
    fullname: Kyaw
– volume: 6
  start-page: 4180
  issue: 23
  year: 2014
  ident: 10.1016/j.bioflm.2024.100192_bib72
  article-title: Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: limitations of in vitro testing for nanosafety
  publication-title: Nanoscale
  doi: 10.1039/C4NR04970E
  contributor:
    fullname: Kim
– volume: 98
  start-page: 50
  year: 2016
  ident: 10.1016/j.bioflm.2024.100192_bib75
  article-title: Biofilm inhibitory effect of chlorhexidine conjugated gold nanoparticles against Klebsiella pneumoniae
  publication-title: Microb Pathog
  doi: 10.1016/j.micpath.2016.06.016
  contributor:
    fullname: Ahmed
– volume: 7
  year: 2016
  ident: 10.1016/j.bioflm.2024.100192_bib23
  article-title: Interspecific bacterial interactions are reflected in multispecies biofilm spatial organization
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2016.01366
  contributor:
    fullname: Liu
– year: 2023
  ident: 10.1016/j.bioflm.2024.100192_bib64
  article-title: pH-responsive polymeric nanomaterials for the treatment of oral biofilm infections
  publication-title: Colloids Surf B Biointerfaces
  contributor:
    fullname: Jeong
– volume: 211
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib49
  article-title: Inhibitory activities of phloroglucinol-chitosan nanoparticles on mono- and dual-species biofilms of Candida albicans and bacteria
  publication-title: Colloids Surf B Biointerfaces
  doi: 10.1016/j.colsurfb.2021.112307
  contributor:
    fullname: Khan
– volume: 8
  start-page: 68
  issue: 1
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib61
  article-title: Translational challenges and opportunities in biofilm science: a BRIEF for the future
  publication-title: NPJ Biofilms Microbiomes
  doi: 10.1038/s41522-022-00327-7
  contributor:
    fullname: Highmore
– volume: 11
  year: 2021
  ident: 10.1016/j.bioflm.2024.100192_bib79
  article-title: Subinhibitory concentrations of biogenic silver nanoparticles affect motility and biofilm formation in Pseudomonas aeruginosa
  publication-title: Front Cell Infect Microbiol
  doi: 10.3389/fcimb.2021.656984
  contributor:
    fullname: Saeki
– volume: 24
  start-page: 203
  issue: 3
  year: 1997
  ident: 10.1016/j.bioflm.2024.100192_bib44
  article-title: A simple artificial urine for the growth of urinary pathogens
  publication-title: Lett Appl Microbiol
  doi: 10.1046/j.1472-765X.1997.00378.x
  contributor:
    fullname: Brooks
– volume: 170
  year: 2022
  ident: 10.1016/j.bioflm.2024.100192_bib89
  article-title: Superior inhibition of virulence and biofilm formation of Pseudomonas aeruginosa PAO1 by phyto-synthesized silver nanoparticles through anti-quorum sensing activity
  publication-title: Microb Pathog
  doi: 10.1016/j.micpath.2022.105678
  contributor:
    fullname: Kumar
– volume: 54
  start-page: 667
  issue: Pt 7
  year: 2005
  ident: 10.1016/j.bioflm.2024.100192_bib42
  article-title: Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung
  publication-title: J Med Microbiol
  doi: 10.1099/jmm.0.45969-0
  contributor:
    fullname: Sriramulu
– volume: 17
  start-page: 141
  issue: 3
  year: 2019
  ident: 10.1016/j.bioflm.2024.100192_bib81
  article-title: Drug combinations: a strategy to extend the life of antibiotics in the 21st century
  publication-title: Nat Rev Microbiol
  doi: 10.1038/s41579-018-0141-x
  contributor:
    fullname: Tyers
SSID ssj0002313720
Score 2.3375518
Snippet The increasing incidence of antimicrobial resistance exhibited by biofilm-forming microbial pathogens has been recognized as one of the major issues in the...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 100192
SubjectTerms Antibiofilm
Antivirulence
Host-mimicking media
Pyoverdine
Silver nanoparticles
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yIHgRv31-EcFrMUnTpvW2issiKIIu7C3kq9rFTZfX18Pzr3cmaZdXPezFQy9NSJuZSeYXMvMbQt7UQvFONawA31YWMkhZWG-7ggdAx7VrQi0wwfnzl_r0TH46r84PSn1hTFimB86CewsjtVXHQukaKx3rrPPMA6zgsPP61oe0-7L24DB1kUhcOJZfWXLlUkCX7YfuFyafC5mYh1qx8kWJsn_lkv6FnH9HTh64opN75O6MIelx_vf75FaID8jtXFVy_5Bcfusx3JlGE-FEPAe-0XEfAeuN_e_gKeaU0K9jmPwAVmhGasJ2-tHHYTT0ao9BneDRwjt6HDGjBIt6X1ITPTxYa2I7pUQlajAra3xEzk4-fv9wWsxVFQpXlWxX-NIy0zYW5KcEaDCYrhaOO8OFcLKTnautYsxxrpyUZeNRZyBxLpVt4HBUPiZHcYjhKaEc6cHwptTXAARE2RrhuXBOBSMq3_INKRb56qtMnqGXqLILnfWhUR8662ND3qMSrvsi9XV6AQahZ3npmwxiQ9SiQj2jiIwOYKj-hs-_XjSuYZHhzYmJYZhGnc6hyJQDfZ5kC7j-ybKppFQSWpqVbaxmsW6J_c9E5A12C_CoLZ_9j3k_J3dwLjmM7QU52m2n8BIA086-SmvjD7_nFxk
  priority: 102
  providerName: Directory of Open Access Journals
Title Silver nanoparticles synthesized from Pseudomonas aeruginosa pyoverdine: Antibiofilm and antivirulence agents
URI https://dx.doi.org/10.1016/j.bioflm.2024.100192
https://www.ncbi.nlm.nih.gov/pubmed/38544742
https://search.proquest.com/docview/3014005092
https://pubmed.ncbi.nlm.nih.gov/PMC10966193
https://doaj.org/article/1f795f0e3c8b4c0fbcd0d6501362d9de
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZJoNBL6bubtkGFXp21ZFm2e0tDQyikBNpAbkIvpw5ZeVmvD9tf3xnZDnF7KPTgi-WHpBkxn-xvviHko-QFq4syTSC2ZYnwQiTGmTphHtCxtKWXHBOcL77J8yvx9Tq_3iNyyoWJpH1rmuNwtzoOzc_IrVyv7HLiiS0vL04Z4G4A_tlyn-yDhz7Yo99GAReGpVemPLlI5jJNW99h4jkXUXWo4rM4FOX6Z-Hob7j5J2vyQRg6e0qejPiRngz9fEb2fHhOHg0VJXcvyOp7g1RnGnSA3fA4GNrtAuC8rvnlHcV8EnrZ-d614IG6o9pv-psmtJ2m6x0SOiGa-U_0JGA2CRb0XlEdHBxYZ2LTxyQlqjEjq3tJrs6-_Dg9T8aKConNs3SbuMykuioNRK2Cg_W8riW3zGrGuRW1qK00RZpaxgorRFY6tJeTAKoKU8KcZ6_IQWiDf0MoQ2kw_EvqJIAAnlWaO8atLbzmuavYgiTT_Kr1IJyhJkbZrRrsodAearDHgnxGI9xfi7LX8US7uVHjfClwqyqvU5_Z0gib1sY6eH-OunPcVc4vSDGZUI0IYkAG8KjmH6__MFlcwQLDvyY6-LbvVNyDokoOXPN68ID7TmZlLkQhoKWc-cZsFPMW8Oko4j358OH_3_qWPMYRDMS1d-Rgu-n9e4BIW3MUPy0cxXXxG6XsFmU
link.rule.ids 230,315,730,783,787,867,888,2109,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEYIL78LyNBLXbGPHeXErFdUC3aoSrejN8iuQ0nVWm81h--uZcTZVtxwQHHKJs0lm_VnzWfnmG0LeZzxnVV7EEeS2JBJOiEhbXUXMATvOTOEyjgXO06Nsciq-nKVnWyQbamGCaN_oeuwvZmNf_wzayvnM7A46sd3j6T4D3g3EP9m9RW7Dgo3FtV36ebBwYdh8ZaiUC3IuXTfVBZaecxF8h0q-kYmCYf9GQvqTcN7UTV5LRAcPyPchhF5_8mvcLfXYXN5wd_z3GB-S-2tuSvf68Udky_nH5E7frXL1hMy-1Sijpl552Gmvb0LblQcO2daXzlKsVaHHretsA-hWLVVu0cF7Na2i8xWKRSFTug90z2OlCjYLn1HlLRzYw2LRhQIoqrDaq31KTg8-nexPonW3hsikSbyMbKJjVRYaMmLOARlOVRk3zCjGuRGVqEym8zg2jOVGiKSwiAWbAWHLdQGxJjtk2zfePSeUoe0YfoG1GRAMnpSKW8aNyZ3iqS3ZiETDzMl5b8ohB7XauexnWuJMy36mR-QjTu_VtWipHU40ix9y_X9JgGyZVrFLTKGFiSttLDw_RU87bkvrRiQfwCHX7KRnHXCr-i-PfzdgScLixS8yyruma2XY36IDD1zzrMfW1UsmRSpELmCk2EDdRhSbI4ClYBA-YOfF___0Lbk7OZkeysPPR19fknsYTS-Qe0W2l4vOvQYqttRvwrr7DSsZN5o
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLagCMSFvTCsRuKamdhxNm6lMCpLq5GgUiUOlrdASscZTSaH6a_nvSxVUw5IPeSSeJK88We9z8r3vkfIu4SnrEizMIDcFgXCCRFoq4uAOWDHiclcwrHA-fAoOTgWX07ik15VWfeySm90OfVny6kvf7faytXSzAad2GxxuM-AdwPxj2YrW8xukluwaMPk0k79tLVxYdiAZaiWayVduqyKMyw_56L1Hsr5KBu1pv2jpPQv6byqnbyUjOb3yc8hjE6D8mfabPTUnF9xeLxenA_IvZ6j0r1uzENyw_lH5HbXtXL7mCy_lyinpl552HH3N6L11gOXrMtzZynWrNBF7RpbAcpVTZVbN_BuVa3oaouiUciY7j3d81ixgk3Dl1R5Cwf2slg3bSEUVVj1VT8hx_NPP_YPgr5rQ2DiKNwENtKhyjMNmTHlgBCnioQbZhTj3IhCFCbRaRgaxlIjRJRZxIRNgLilOoN4o12y4yvvnhHK0H4Mv8TaBIgGj3LFLePGpE7x2OZsQoJh9uSqM-eQg2rtVHazLXG2ZTfbE_IBp_hiLFprtyeq9S_Z_18SoJvHRegik2lhwkIbC8-P0duO29y6CUkHgMiepXTsA25V_ufxbwc8SVjE-GVGeVc1tWz3uejEA2Oedvi6eMkoi4VIBVzJRsgbRTG-AnhqjcIH_Dy__k_fkDuLj3P57fPR1xfkLgbT6eRekp3NunGvgJFt9Ot26f0Fv0Q6Gg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Silver+nanoparticles+synthesized+from+Pseudomonas+aeruginosa+pyoverdine%3A+Antibiofilm+and+antivirulence+agents&rft.jtitle=Biofilm&rft.au=Tabassum%2C+Nazia&rft.au=Khan%2C+Fazlurrahman&rft.au=Jeong%2C+Geum-Jae&rft.au=Jo%2C+Du-Min&rft.date=2024-06-01&rft.pub=Elsevier&rft.eissn=2590-2075&rft.volume=7&rft_id=info:doi/10.1016%2Fj.bioflm.2024.100192&rft.externalDBID=PMC10966193
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2590-2075&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2590-2075&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2590-2075&client=summon